Yasue Horiuchi Selected Research

Yasue Horiuchi Research Topics

Disease

20	Schizophrenia (Dementia Praecox) 01/2022 - 03/2006
7	Neoplasms (Cancer) 05/2022 - 01/2016
5	Mental Disorders (Mental Disorder) 01/2022 - 11/2015
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022 - 01/2021
2	Psychotic Disorders (Schizoaffective Disorder) 08/2021 - 01/2018
2	Cognitive Dysfunction 01/2021 - 09/2014
2	Tardive Dyskinesia 04/2010 - 04/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	AIDS-Related Complex (ARC) 01/2021
1	Insulin Resistance 01/2021
1	Carcinoma (Carcinomatosis) 10/2019
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 01/2018
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2018
1	Esophageal Stenosis (Esophageal Stricture) 03/2017
1	Gastrinoma 03/2017
1	Esophageal Diseases 03/2017
1	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 03/2017
1	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 03/2017
1	Carcinogenesis 01/2017
1	22q11 Deletion Syndrome 10/2013
1	Mania (Manias) 01/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 04/2008
1	Dyskinesias (Dyskinesia) 04/2008
1	Fasciculation (Fasciculations) 05/2007
1	Mood Disorders (Mood Disorder) 01/2004
1	Absence Epilepsy (Childhood Absence Epilepsy) 06/2003
1	Generalized Epilepsy with Febrile Seizures Plus 06/2003
1	Febrile Seizures (Febrile Seizure) 06/2003

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 09/2021 - 02/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2007
4	pentosidineIBA 01/2022 - 09/2014
4	Antipsychotic Agents (Antipsychotics)IBA 01/2018 - 04/2008
3	CannabinoidsIBA 01/2022 - 05/2010
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2006
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2014
2	Advanced Glycation End ProductsIBA 08/2021 - 01/2021
2	MicroRNAs (MicroRNA)IBA 01/2021 - 10/2013
2	Vitamin B 6IBA 01/2021 - 01/2021
2	CB2 Cannabinoid ReceptorIBA 07/2018 - 05/2010
2	NucleotidesIBA 01/2017 - 01/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2012 - 04/2008
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2008 - 04/2008
2	GABA-A Receptors (GABA(A) Receptor)IBA 01/2004 - 06/2003
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2022
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Glucuronic Acid (Glucuronate)IBA 01/2021
1	Early Growth Response Transcription FactorsIBA 01/2021
1	PyridoxamineIBA 01/2018
1	Thiamine (Aneurin)FDA Link 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2017
1	GastrinsIBA 03/2017
1	SteroidsIBA 03/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2015
1	AlbuminsIBA 11/2015
1	PyridoxalIBA 09/2014
1	Biological ProductsIBA 09/2014
1	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2013
1	EndocannabinoidsIBA 05/2010
1	Dopamine AntagonistsIBA 04/2010
1	P-2 (P 2)IBA 04/2010
1	perlecanIBA 04/2010
1	GABA Receptors (GABA Receptor)IBA 04/2008
1	metabotropic glutamate receptor 7IBA 04/2008
1	LuciferasesIBA 04/2008
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 12/2006
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2004
1	gamma-Aminobutyric Acid (GABA)IBA 01/2004

Therapy/Procedure

3	Precision Medicine 05/2022 - 01/2021
1	Ligation 01/2021
1	Semiconductors 01/2021
1	Pancreaticoduodenectomy 03/2017
1	Therapeutics 03/2017